Heterocyclic compounds useful as Raf kinase inhibitors
Details for Australian Patent Application No. 2008273017 (hide)
International Classifications
Event Publications
28 January 2010 PCT application entered the National Phase
PCT publication WO2009/006404 Priority application(s): WO2009/006404
12 January 2012 Assignment before Grant
Biogen Idec MA Inc.; Sunesis Pharmaceuticals, Inc. The application has been assigned to Millennium Pharmaceuticals, Inc.; Sunesis Pharmaceuticals, Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008273030-Methods for extraction and purification of components of biological samples
2008273002-Pyrimidine derivatives useful as Raf kinase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser